FELOCELL CVR

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

FELINE ENTERITIS (PANLEUCOPENIA) VIRUS (FPV), SNOW LEOPARD STRAIN LIVE ATTENUATED, FELINE RHINOTRACHEITIS VIRUS (FVR), STRAIN FVRM LIVE ATTENUATED, FELINE CALICIVRUS, STRAIN F9 LIVE ATTENUATED

Available from:

Elanco Animal Health, Eli Lilly and Company Limited

ATC code:

QI06AD04

INN (International Name):

FELINE ENTERITIS (PANLEUCOPENIA) VIRUS (FPV), SNOW LEOPARD STRAIN LIVE ATTENUATED, FELINE RHINOTRACHEITIS VIRUS (FVR), STRAIN FV

Dosage:

Unknown

Pharmaceutical form:

Lyophilisate and solvent for solution for injection

Prescription type:

POM

Therapeutic group:

Feline

Therapeutic area:

Feline panleucopenia virus / parvovirus vaccine + Feline rhinotracheitis virus vaccine + Feline cal

Therapeutic indications:

Immunological - Live Vaccine

Authorization status:

Authorised

Authorization date:

2010-12-10

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
FELOCELL CVR.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 1 ml dose (when reconstituted) contains:
ACTIVE SUBSTANCE(S)
Live attenuated feline enteritis (panleucopenia) virus (FPV), Snow Leopard strain
minimum : 10
3.0
*CCID
50
Live attenuated feline rhinotracheitis virus (FVR), strain FVRm
minimum : 10
5.0
CCID
50
Live attenuated Calicivirus (FCV), strain F9
minimum : 10
5.5
CCID
50
*CCID
50
= Cell culture infectious dose
EXCIPIENTS:
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Lyophilisate and solvent for solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats from 9 weeks of age.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Felocell CVR is a live attenuated vaccine designed to reduce the clinical signs of disease caused by feline enteritis
(panleucopenia) virus, feline rhinotracheitis virus and calicivirus in cats. The onset of immunity is from 3 weeks post-
vaccination and last_S _for 1 year.
4.3 CONTRAINDICATIONS
Unhealthy animals should not be vaccinated.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not vaccinate animals for at least one month after cessation of corticosteroid treatment. Due to the nature of post-
vaccination viral shedding, it is advised that vaccinated kittens are kept away from pregnant queens for a period of
three weeks.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 16/07/2014_
_CRN 7017878_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS
In the case of accidental self-injection seek medical advi